Evidence map›Paper›PMID 34726952›Full record

ArticleScience signaling2021

Mechanosensing by TRPV4 mediates stiffness-induced foreign body response and giant cell formation.

Rishov Goswami, Rakesh K Arya, Shweta Sharma, Bidisha Dutta, Dimitar R Stamov, Xiaoping Zhu, Shaik O Rahaman

Open access · greenAbstract read
In one paragraph

Article in Science signaling, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. A novel role for TRPV1 in macrophage giant cell formation.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. TRPV4-Mediated Mechanosensing Regulates the Endothelial-to-Mesenchymal Transition: Implications for Atherosclerosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rishov GoswamiDepartment of Nutrition and Food Science, University of Maryland, College Park, MD 20742, USA.ORCID 0000-0002-3334-8818
Rakesh K AryaDepartment of Nutrition and Food Science, University of Maryland, College Park, MD 20742, USA.ORCID 0000-0002-1083-3159
Shweta SharmaDepartment of Nutrition and Food Science, University of Maryland, College Park, MD 20742, USA.ORCID 0000-0002-6160-1331
Bidisha DuttaDepartment of Nutrition and Food Science, University of Maryland, College Park, MD 20742, USA.ORCID 0000-0003-4639-8176
Dimitar R StamovJPK BioAFM Business, Nano Surfaces Division, Bruker Nano GmbH, Am Studio 2D, 12489 Berlin, Germany.ORCID 0000-0003-3140-3235
Xiaoping ZhuDepartment of Veterinary Medicine, University of Maryland, College Park, MD 20742, USA.
Shaik O RahamanDepartment of Nutrition and Food Science, University of Maryland, College Park, MD 20742, USA.
University of Maryland, College Park · USBruker (United States) · US

Funding

Role of TRPV4 mechanotransduction in foreign body responseR01EB024556 · NIBIB · UNIV OF MARYLAND, COLLEGE PARK · PI RAHAMAN, SHAIK O, ZHU, XIAOPING · 2017 to 2020
$1.7M
NIBIB NIH HHS R01 EB024556
6 · The paper itself

Abstract

Implantation of biomaterials or devices into soft tissue often leads to the development of the foreign body response (FBR), an inflammatory condition that can cause implant failure, tissue injury, and death of the patient. Macrophages accumulate and fuse to generate destructive foreign body giant cells (FBGCs) at the tissue-implant interface, leading to the development of fibrous scar tissue around the implant that is generated by myofibroblasts. We previously showed that the FBR in vivo and FBGC formation in vitro require transient receptor potential vanilloid 4 (TRPV4), a mechanosensitive ion channel. Here, we report that TRPV4 was required specifically for the FBR induced by implant stiffness independently of biochemical cues and for intracellular stiffening that promotes FBGC formation in vitro. TRPV4 deficiency reduced collagen deposition and the accumulation of macrophages, FBGCs, and myofibroblasts at stiff, but not soft, implants in vivo and inhibited macrophage-induced differentiation of wild-type fibroblasts into myofibroblasts in vitro. Atomic force microscopy demonstrated that TRPV4 was required for implant-adjacent tissue stiffening in vivo and for cytoskeletal remodeling and intracellular stiffening induced by fusogenic cytokines in vitro. Together, these data suggest a mechanism whereby a reciprocal functional interaction between TRPV4 and substrate stiffness leads to cytoskeletal remodeling and cellular force generation to promote FBGC formation during the FBR.

Indexed as

Foreign BodiesTRPV Cation ChannelsGiant CellsHumansTRPV4 protein, humanTRPV Cation Channels

Identifiers

PMID34726952
PMCPMC9976933
OpenAlexW3210640813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.